All told, EyePoint is selling nearly 4.03 million shares of its common stock in the new issue in a public offering. Meanwhile, "certain investors in lieu of common stock" will be able to obtain pre-funded warrants to buy up to more than 3.27 million shares of said equity, at a price of $13.74 apiece. That, plus the exercise price of $0.01 apiece, matches the $13.75 price of the direct share issue.